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Summary culties, facial angioﬁbromas (adenoma sebaceum), periun-
gual ﬁbromas, shagreen patches, and hypopigmented mac-
Tuberous sclerosis is an autosomal dominant trait char- ules (Gomez 1988). Renal manifestations are common and
acterized by the development of hamartomatous include angiomyolipomas, cystic disease, and, exception-
growths in many organs. Renal cysts are also a frequent ally, renal cell carcinoma (Cook et al. 1996). In patients
manifestation. Major genes for tuberous sclerosis and with tuberous sclerosis, renal causes of death are second
autosomal dominant polycystic kidney disease, TSC2 only to CNS causes (Shepherd et al. 1991). The radiologi-
and PKD1, respectively, lie adjacent to each other at cal andmacroscopic appearances of cystic disease resemble
chromosome 16p13.3, suggesting a role for PKD1 in the autosomal dominant polycystic kidney disease (ADPKD)
etiology of renal cystic disease in tuberous sclerosis. We (Torres et al. 1994). However, clinical onset is often early
studied 27 unrelated patients with tuberous sclerosis and (Wenzl et al. 1970; Stapleton et al. 1980; Campos et al.
renal cystic disease. Clinical histories and radiographic 1993; Webb et al. 1993; Cook et al. 1996), and the hyper-
features were reviewed, and renal function was assessed. trophic eosinophilic cells of the cystic epithelium are con-
We sought mutations at the TSC2 and PKD1 loci, using sidered to be unique, by some authors (Elkin and Bernstein
pulsed ﬁeld– and conventional-gel electrophoresis and 1969; Bernstein 1993).
FISH. Twenty-two patients had contiguous deletions of Two tuberous sclerosis genes, termed ‘‘TSC1’’ and
TSC2 and PKD1. In 17 patients with constitutional dele-
‘‘TSC2,’’ have been localized to chromosomes 9q34
tions, cystic disease was severe, with early renal insufﬁ- (Fryer et al. 1987) and 16p13.3 (Kandt et al. 1992),
ciency. One patient with deletion of TSC2 and of only respectively. The TSC2 gene has been identiﬁed and
the 3 UTR of PKD1 had few cysts. Four patients were characterized (European Chromosome 16 Tuberous
somatic mosaics; the severity of their cystic disease var- Sclerosis Consortium 1993). It lies immediately adjacent
ied considerably. Mosaicism and mild cystic disease also to PKD1, the major gene for ADPKD (European Poly-
were demonstrated in parents of 3 of the constitutionally cystic Kidney Disease Consortium 1994), raising the
deleted patients. Five patients without contiguous dele- possibility that PKD1 plays a role in the etiology of
tions had relatively mild cystic disease, 3 of whom had renal cystic disease in tuberous sclerosis. We previously
gross rearrangements of TSC2 and 2 in whom no muta- investigated 6 patients with tuberous sclerosis and severe
tion was identiﬁed. Signiﬁcant renal cystic disease in polycystic kidney disease who had presented during the
tuberous sclerosis usually reﬂects mutational involve- ﬁrst few months of life (Brook-Carter et al. 1994). In
ment of the PKD1 gene, and mosaicism for large dele- each case, a submicroscopic deletion at chromosome
tions of TSC2 and PKD1 is a frequent phenomenon. 16p13.3, involving both the TSC2 and the PKD1 genes,
was identiﬁed. In order to establish whether PKD1 plays
a more general role in renal cystic disease in tuberousIntroduction
sclerosis, we have now investigated 27 unrelated pa-
Tuberous sclerosis is an autosomal dominant trait recog- tients with tuberous sclerosis and renal cystic disease of
nized particularly for its neurological and dermatological varying degrees of severity.
manifestations. These include seizures and learning difﬁ-
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Table 1
Presentation of Renal Cystic Disease
Age at Presentation or Method
Subject Sex Diagnosis of Diagnosis
TSC2/PKD1-deletion case:
1 Male 3 mo Abdominal masses
2 Male 1 mo Abdominal distention
3 Male 4 mo Abdominal masses
4 Male 6 mo Abdominal distention
5 Male 5 mo Abdominal masses
6 Male 6 mo Abdominal masses
7 Male 1 mo Abdominal masses
8 Male 2 years Abdominal masses
9 Female 6 mo Abdominal masses
10 Male 7 mo Abdominal distention
11 Male 8 mo Abdominal masses
12 Male 10 years Ultrasound screening
13 Female 21 mo Ultrasound screening
14 Male 3 mo Abdominal masses
15 Male 6 mo Abdominal distention
16 Female 4 mo Abdominal distention
17 Female 7 mo Ultrasound screening
PKD1 3-UTR deletion case:
18 Female 45 years Ultrasound screening
Mosaic case:
19 Female 5 years Hematuria, abdominal masses
20 Male 5 mo Abdominal distention
21 Female 5 years Abdominal masses
22 Female 3 years Abdominal masses
Other cases (mutation):
23 (TSC2 deletion) Female 37 years Ultrasound screening
24 (TSC2 deletion) Female 35 years Ultrasound screening
25 (inversion) Female 2 years Ultrasound screening
26 (no mutation identiﬁed) Male 13 years Ultrasound screening
27 (no mutation identiﬁed) Female 27 years Ultrasound screening
Mosaic parent of TSC2/
PKD1-deletion cases:
Mother of patient 7 . . . 37 years Ultrasound screening
Father of patient 12 . . . 35 years Ultrasound screening
Father of patient 13 . . . 30 years Ultrasound screening
through a call for patients with tuberous sclerosis and Diagnostic Criteria Committee of the National Tuberous
renal cystic disease. Six of these cases have been reported Sclerosis Association (Roach et al. 1992). Renal ultrasound
elsewhere (patients 1 [WS-53], 2 [WS-194], 3 [WS-215], ﬁlms were reviewed, and the presence or absence, the later-
4 [WS-219], 5 [WS-227], and 6 [WS-250]; Brook-Carter ality, and the multiplicity of renal cysts and of angiomyoli-
et al. 1994). Nine additional patients were identiﬁed pomas were recorded. In cases for whom assessment of
from among a cohort of 90 sequentially ascertained pa- renal cystic disease was problematic, owing to, for exam-
tients with tuberous sclerosis who underwent prospec- ple, coexisting renal angiomyolipomas, abdominal com-
tive ultrasound assessment for renal involvement, in the puted tomograms and magnetic nuclear-resonance images
absence of signs or symptoms of renal disease. Twenty- were obtained and were reviewed. Plasma creatinine levels
four of the 27 cases were apparently sporadic, with no were measured, and estimates of the glomerular ﬁltration
family history of either tuberous sclerosis or polycystic rate (GFR) based on the clearance of creatinine, of
kidney disease. Three cases had parents with tuberous Tc99DPTA (diethylenetriaminepentaacetic acid) or of
sclerosis and cystic kidneys. Cr51EDTA, were recorded. When this was not possible,
the GFR was estimated from plasma creatinine levels by
Clinical Evaluation use of the Schwartz formula (Schwartz et al. 1976), for
those patients õ17 years of age, or the formula of Cock-All patients fulﬁlled the deﬁnitive diagnostic criteria for
tuberous sclerosis, described by Gomez (1988) and by the croft and Gault (1976), for adults.
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Identiﬁcation and Characterization of Mutations 27 patients (ﬁg. 1). Most deletions removed substantial
portions or all of both genes. However, in one caseWe have constructed previously a restriction map
(patient 16), the probe (BFS5) to the 3 ends of the PKD1around the TSC2 and PKD1 loci and have described
and TSC2 genes was partially present. To determine ifmost of the probes used in this study (European Chro-
the TSC2 gene was disrupted, a breakpoint fragmentmosome 16 Tuberous Sclerosis Consortium 1993; Euro-
was cloned and was sequenced (see Patients and Meth-pean Polycystic Kidney Disease Consortium 1994;
ods for details); 84 bp of the TSC2 coding sequenceHughes et al. 1995). The newly described probe BFS5
were deleted. In patients 17 and 18, the deletions in-is a 4.3-kb NotI/HindIII fragment of probe CW23. For
volved only the most 3 part of PKD1. The breakpointPFGE analysis of patient samples, high-molecular-
in patient 17 was localized within the coding region ofweight DNA was prepared from peripheral blood leuko-
the ﬁnal exon of PKD1, whereas the breakpoint in pa-cytes, in agarose plugs (Hermann et al. 1987), was di-
tient 18 was localized within the 3 UTR.gested with the appropriate restriction enzymes, and was
Deletions and an inversion disrupting TSC2.—Grossresolved by use of a BioRad CHEF DRII apparatus and
rearrangements of TSC2 without PKD1 involvement1% agarose gels. For conventional gel electrophoresis,
were found in three patients (ﬁg. 1A). Two of theseDNA was extracted by standard methods (Sambrook et
deletions in TSC2 have been reported elsewhere (foral. 1989), was digested with various enzymes, and was
patients 23 [WS-9] and 24 [WS-11]; European Chromo-resolved by use of 0.5%–1.0% agarose gels. Blotting
some 16 Tuberous Sclerosis Consortium 1993). Theand hybridization were by conventional methods (Sam-
third case, patient 25, was shown to have an inversionbrook et al. 1989). A phosphoimager (STORM 860;
of É600 kb of DNA, by use of a combination of PFGEMolecular Dynamics) was used to quantify the
and FISH analysis. The proximal breakpoint was withinbreakpoint-fragment intensity in patient F13.
TSC2, and, therefore, the inverted DNA segment layA general strategy for detection of deletions at the
entirely distal to PKD1 (ﬁg. 1A).TSC2 and PKD1 loci, by use of pulsed ﬁeld–gel electro-
Somatic mosaicism.—In patients 19, 20, 21, and 22,phoresis (PFGE), has been described elsewhere (Brook-
autoradiography revealed breakpoint fragments ofCarter et al. 1994). Restriction fragments that span the
lower signal intensity than that of their normal counter-area were assayed with probes located proximal to and
parts. This suggested that the patients might be somaticdistal to the genes. Abnormal fragments detected by
mosaics, with only a proportion of their cells carryingﬂanking probes, but not by one or more probes within
a deleted chromosome. FISH analysis using probes map-the genes, were considered to be indicative of deletions.
ping within the deletions conﬁrmed and quantiﬁed mo-The precise areas deleted then were established by hy-
saicism (ﬁg. 2 and table 2). PFGE and FISH analysis ofbridization of further genomic and cDNA fragments
samples from the father of patient 12 (individual F12)from between the ﬂanking probes. Deletions ú10–20
and the mother of patient 7 (individual M7) showedkb could be detected by this method. Smaller deletions
that they also were mosaics and that their deleted chro-were sought by conventional gel electrophoresis, with
mosomes had been transmitted to their offspring (ﬁg.1concentration on the adjacent 3 regions of the TSC2
and table 2). PFGE analysis of the father of patient 13and PKD1 genes.
(individual F13) also suggested mosaicism, but, sinceFISH was undertaken by use of probes mapping
no probe suitable for FISH was deleted completely, thewithin the deleted areas. This enabled conﬁrmation of
frequency of the mutant allele was assessed by measure-deletion mutations and quantiﬁcation of somatic mosa-
ment of the signal from a BamHI breakpoint fragment,icism. The methods used have been described elsewhere
on a Southern blot detected by probe CW23. The mu-(Brook-Carter et al. 1994).
tant allele was estimated to be present in 15% of leuko-
Sequencing of the Breakpoint in Patient 16 cytes.
Primers for intron 40 of TSC2 (1316D; 5-CAAGCC-
GCCTCTGCCTTC-3) and exon 11 of PKD1 (1316P; Clinical Evaluation
5-TGACGTGGTCTCCCCAGTGG-3) were designed Cases with deletions involving TSC2 and PKD1.—The
to amplify a breakpoint fragment from genomic DNA presentation and course of renal cystic disease in the 17
of patient 16. PCR buffers and conditions were as de- patients with nonmosaic deletions of the coding regions
scribed elsewhere (Harris et al. 1991). The resulting of TSC2 and PKD1 were very similar (table 1), although
fragment of 238 bp was cloned in pZErO and was se- the nonrenal manifestations of tuberous sclerosis varied
quenced. considerably. All 17 patients were found to have en-
larged cystic kidneys during infancy or childhood, withResults
radiographic features resembling advanced ADPKD, at
Genetic Analysis the time of diagnosis (ﬁg. 3). Five patients presented
with cystic kidneys before other features of tuberousDeletions of TSC2 and PKD1.—DNA deletions dis-
rupting both TSC2 and PKD1 were identiﬁed in 22/ sclerosis developed, leading to incorrect initial diagnoses
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Figure 1 Deletions and inversion in patients with tuberous sclerosis and renal cystic disease. A, Map of the TSC2/PKD1 region of chromosome 16. The genomic map is shown
as a blackened bar, with restriction sites for EcoRI (‘‘E’’), MluI (‘‘M’’), and NruI (‘‘R’’) indicated. The hatched region indicates the part of the PKD1 locus that is duplicated elsewhere
on chromosome 16. The locations of exons of the PKD1 gene and the TSC2 gene are shown, and the directions of transcription are indicated by arrows. The genomic probes
(unblackened boxes) and the cDNA probes (hatched boxes) that were used for PFGE (panel B) and for FISH are shown below the map. The regions of DNA deleted in tuberous
sclerosis patients with renal cystic disease are shown above the map. The solid lines indicate the regions deﬁnitely deleted, and the dashed lines indicate regions of uncertainty. The
patients’ numbers are indicated, and the patients who are mosaic for deletions are shown in italics. The proximal inversion breakpoint in patient 25 is illustrated, and the distal
breakpoint lies É600 kb telomeric to TSC2. The 3 ends of the PKD1 and TSC2 genes are expanded below the diagram. The cDNA probes and the restriction sites used to localize
the proximal breakpoints in patients 17 and 18 are indicated. The proximal deletion breakpoint in patient 17 was localized between AlwI (‘‘A’’) and TaqI (‘‘T’’) sites within the
coding region of PKD1, whereas the proximal breakpoint in patient 18 mapped within the 3 UTR, between DraI (‘‘D’’) and PﬂMI (‘‘PM’’) sites. B, Examples of PFGE, to detect
deletions in patients with tuberous sclerosis and renal cystic disease. NruI-digested DNA from a normal control (lane N) and from patients (numbered lanes) were hybridized with
a probe (CW9) distal to TSC2 (left); with a probe (BFS5) containing the 3 regions of TSC2 and PKD1 (middle), and with a probe (N54) proximal to PKD1 (right) (see panel A for
probe locations). Each of the probes detected the same normal fragment of 155 kb. An additional fragment is seen in all patients, by use of CW9, whereas BFS5 is deleted completely
in all cases, except in patient 16, for whom the breakpoint is in the last exon of TSC2. N54 lies proximal to the deletions in patients 12, 13, 16, 9, and 15 but is deleted in patients
14, 7, 8, and 11; the proximal extent of the deletions in these cases was deﬁned with other probes, from the adjacent NruI fragment (data not shown). An example of somatic
mosaicism is illustrated on the left side of the gel. The breakpoint fragment seen in patient 12 also is seen, but at reduced intensity, in the patient’s father (lane F12), suggesting that
the deleted chromosome was present in only a proportion of white blood cells. Mosaicism was conﬁrmed and quantiﬁed by FISH (table 2).
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Table 2
FISH in Patients with Somatic Mosaicism for TSC2/PKD1 Deletions
and in Normal Controls
PERCENTAGE OF CELLS
WITH SIGNAL ON
CHROMOSOME 16, ONb
Both One
SUBJECT(S) PROBEa Homologues Homologue
Patient:
19 JH2A 65 35
20 AH8 76 34
21 JH2A 66 34
22 JH2A 39 61
M7 JH2A 58 42
F12 CW23 76 24
Controls:
1/2/3 JH2A 95/96/97 5/4/3
1/2/3 AH8 89/88/95 11/12/5
1/2/3 CW23 95/92/94 5/8/6
a Positions of probes used for FISH are shown in ﬁgure 1 relative
to the positions of deletions.
b One hundred cells were scored per patient, except for patient 19,
in whom 26 cells were scored.
tients still in the ﬁrst decade of life. GFRs were markedly
reduced in most older patients, and the 3 oldest patients
had reached end-stage renal disease prior to enrollment,
at the ages of 19, 20, and 29 years (ﬁg. 4). One patient
was treated successfully by hemodialysis, another by
chronic ambulatory peritoneal dialysis, and the third did
Figure 2 FISH analysis for patient 19. Cosmid JH2A hybridized
to different metaphase spreads. The cosmid hybridized to the distal
TSC2/PKD1 locus and, more strongly, to the homologous multiple-
copy proximal locus. A, Nondeleted cell, with proximal and distal
signals indicated by arrows. B, Cell deleted at the TSC2/PKD1 locus
(indicated by an arrow). In patient 19, 35% of cultured lymphocytes
were deleted for JH2A (table 2).
of early onset ADPKD or of autosomal recessive poly-
cystic kidney disease. Serial radiography revealed in-
creasing cyst size and reduction of residual parenchyma,
in some patients. Small echogenic areas consistent with
angiomyolipomata developed in 2 patients. Figure 3 Result of renal ultrasound for patient 7 (6 years of
Twelve patients required antihypertensive treatment. age). The transverse section through the right kidney shows multiple
cystic areas throughout and largely replacing the kidney.GFRs were normal or only slightly reduced among pa-
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Figure 4 GFRs in 30 patients with tuberous sclerosis and renal cystic disease. For each patient, the most recent estimate of GFR, corrected
for body surface area, is plotted relative to a nomogram of GFRs corrected for body surface area at different ages (mean and {2 SD; from
McCrory 1972). Patients are identiﬁed by their individual numbers (1–27), and GFRs in the affected parents of patients 7, 12, and 13 are
indicated as ‘‘M7,’’ ‘‘F12,’’ and ‘‘F13,’’ respectively. The curve of best ﬁt is for cases with constitutional deletions involving the coding regions
of TSC2 and PKD1.
not receive medical intervention and died. Bilateral open but not PKD1, had numerous angiomyolipomata and a
small number of cysts, in each kidney. Mixed angiomyo-renal biopsy was undertaken for patient 16. Pathological
examination revealed many cysts, ranging in size from lipomata and cysts also were present in patients 26 and
27, in whom no mutation could be identiﬁed. Moder-microscopic to ú1 cm in diameter. The histopathologi-
cal features (ﬁg. 5) were indistinguishable from those
described elsewhere for renal cystic disease in tuberous
sclerosis (Bernstein 1993).
Mosaics.—The severity of renal cystic disease and of
other features of tuberous sclerosis varied widely among
the seven patients with mosaicism for deletions involv-
ing TSC2 and PKD1. Cystic disease in the three mosaic
parents was recognized only in adult life, following diag-
nosis of their more severely affected children. The radio-
graphic appearances were similar to those of the consti-
tutionally deleted cases, but renal function was better
preserved (ﬁg. 4).
Deletion of the 3 UTR of PKD1.—In patient 18, the
deletion involved TSC2 but only the 3 UTR of PKD1.
The patient had adenoma sebaceum and periungual ﬁ-
bromas, which are skin stigmata that are both diagnostic
of tuberous sclerosis. At 45 years of age, the patient
underwent prospective renal ultrasound and was found
to have a few cysts and multiple angiomyolipomas, in
Figure 5 Renal histopathology in patient 16. The hematoxylin-both kidneys. Renal function was normal.
and eosin-stained section is shown at 500 1 magniﬁcation. The cysticCases without PKD1 involvement.—In ﬁve patients epithelium (top) comprises large cells with strongly eosinophilic and
there was no evidence of structural disruption of PKD1. abundant cytoplasm. Mitotic ﬁgures and piling up of the epithelium
into small mounds also were seen occasionally (not shown).Patients 23 and 24, with large deletions involving TSC2
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ately severe renal cystic disease was present in patient We found that the histopathological features of renal
cystic disease in patient 16, who had a deletion involving25, who had an inversion disrupting TSC2 but not
PKD1. TSC2 and PKD1, were indistinguishable from those in
previously reported cases (Elkin and Bernstein 1969;
Discussion Bernstein 1993) in whom the mutational basis had not
been determined. It is likely that these cases also hadA possible role for PKD1 in renal cystogenesis in tu-
berous sclerosis was suggested by Kandt et al. (1992) deletions involving both genes. Renal cystic disease asso-
ciated with the contiguous deletion of TSC2 and PKD1when TSC2 was mapped to the region of chromosome
16 containing PKD1. Once isolated, TSC2 and PKD1 appears to differ from ADPKD, both histopathologically
and in terms of age of onset and severity. This couldwere shown to lie immediately adjacent to one another,
and deletions involving both genes were identiﬁed in six reﬂect the combined effects of mutation of TSC2 and
PKD1 in the developing kidney. The nature of the PKD1patients with tuberous sclerosis and severe early onset
polycystic kidney disease (Brook-Carter et al. 1994). mutation also could be important. The large deletions
that we identiﬁed in patients with tuberous sclerosis canThe present study establishes a more general role for
PKD1 in the etiology of renal cystic disease in tuberous be expected to inactivate PKD1. In contrast, the conse-
quences of the more subtle mutations so far identiﬁedsclerosis. This may be mediated via a number of muta-
tional mechanisms, apparently accounting for at least in patients with ADPKD (Peral et al. 1995, 1996; Turco
et al. 1995) are less clear, and, perhaps surprisingly,some of the observed variation in disease severity. In
this series, constitutional deletions involving the coding both overexpression of the PKD1 product, polycystin,
and loss of heterozygosity have been reported in theregions of both TSC2 and PKD1 were associated consis-
tently with severe early onset renal cystic disease, with cystic epithelium of ADPKD patients (Qian et al. 1996;
Ward et al. 1996; Brasier and Henske 1997).renal enlargement and radiological appearances similar
to those with advanced ADPKD. We did not identify In contrast to the unpredictable nature of many com-
plications of tuberous sclerosis, it can be reasoned thatany similar deletions among 81 unrelated patients with
tuberous sclerosis but without evidence of renal cystic renal cystic disease due to deletion of PKD1 will ‘‘breed
true.’’ Familial occurrence of renal cystic disease in tu-disease, as determined by an ultrasound scan (authors’
unpublished data). The cross-sectional data presented in berous sclerosis already has been noted (Cree 1969;
O’Callaghan et al. 1975), and molecular investigationthis study suggest that the prognosis for renal function
is poor in cases with constitutional deletions involving of familial cases now is warranted. Testing for deletions
at the TSC2 and PKD1 loci also should prove usefulTSC2 and PKD1. However, most of the patients studied
were young, and long-term follow-up is required in or- during investigation of polycystic kidney disease de-
tected in infancy (or even antenatally). In the past, theder to deﬁne the natural history of the renal disease in
this group. Mosaicism for deletions involving TSC2 and initial absence of other features of tuberous sclerosis
frequently had led to diagnostic confusion (Wenzl et al.PKD1 was a frequent phenomenon and was associated
with preserved renal function in some cases. Among 1970; Stapleton et al. 1980; Webb et al. 1993; Brook-
Carter et al. 1994). This now can be avoided, by meansmosaics, disease severity did not correlate with the fre-
quency of the mutant allele in lymphocytes; the level of of clinical awareness and appropriate molecular investi-
gation. Characterization of the deletions also may be ofmosaicism in renal tissue is likely to be more important.
Five of the 27 unrelated patients studied had multiple prognostic value. The data presented here suggest that
progression to end-stage renal disease in late childhoodcysts in both kidneys, but no detectable disruption of
PKD1. All were identiﬁed, through ultrasound screen- or in early adult life may be anticipated for cases with
inactivation of PKD1, whereas a more hopeful progno-ing, as having renal cystic disease. Large rearrangements
of TSC2 were deﬁned in 3 of these patients. Mutations sis may be appropriate when 3-UTR involvement or
mosaicism can be demonstrated.of this type have been demonstrated in very few patients
with tuberous sclerosis (European Chromosome 16 Tu-
berous Sclerosis Consortium 1993). These mutations
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mote regulatory sequences of PKD1 are disrupted. The
We thank many colleagues who helped in the ascertainmentfailure to identify any mutation in 2 of the 27 cases
and evaluation of patients—including Drs. M. Super, C. Ev-might reﬂect the sensitivity of the assays used, since low-
ans, A. David, N. Gallego, J. Osborne, C. Shepherd, G. Nels-
level or tissue-speciﬁc mosaicism could not be excluded. trop, M. Williams, M. Porteous, S. Hodgson, T. Scott, C.
It remains possible that mild cystic disease could be asso- Winearls, P. Jardine, J. Michael, M. Lewis, F. Jewkes, R. New-
ciated with subtle mutations of TSC2 or of TSC1, with- ton, S. Wallace, M. King, C. Maidment, R. Naik, M. Waldron,
out PKD1 involvement. However, signiﬁcant cystic dis- C. Kennedy, V. Annes, R. Posthlethwaite, and M. Dillon, Mrs.
ease has not been documented in affected members of A. Hunt, and Prof. W. Fraser—and we thank Profs. P. Harper
and D. Weatherall, Drs. L. Kearney, R. Snell, N. Thomas, andTSC1 (chromosome 9 linked) families.
/ 9a38$$oc18 09-15-97 13:12:57 ajhgal UC-AJHG
851Sampson et al.: Renal Cysts in Tuberous Sclerosis
C. Ward, and V. Gamble, S. Horsley, and C. Daniels, for their Kandt RS, Haines JL, Smith M, Northrup H, Gardner RJM,
Short MP, Dumars K, et al (1992) Linkage of an importantadvice and technical assistance. This study was supported by
grants from the Tuberous Sclerosis Association (Great Britain) gene locus for tuberous sclerosis to a chromosome 16
marker for polycystic kidney disease. Nat Genet 2:37–41and the Medical Research Council.
McCrory WW (1972) Developmental nephrology. Harvard
University Press, Cambridge
O’Callaghan TJ, Edwards JA, Tobin M, Mookerjee BK (1975)References
Tuberous sclerosis with striking renal involvement in a fam-
Bernstein J (1993) Renal cystic disease in tuberous sclerosis ily. Arch Intern Med 135:1082–1087
complex. Pediatr Nephrol 7:490–495 Peral B, Gamble V, San Millan JL, Strong C, Sloane-Stanley
Brasier JL, Henske EP (1997) Loss of the polycystic kidney J, Moreno F, Harris PC (1995) Splicing mutations of the
disease (PKD1) region of chromosome 16p13 in renal cyst polycystic kidney disease 1 (PKD1) gene induced by intronic
cells supports a loss-of-function model for cyst pathogenesis. deletion. Hum Mol Genet 4:569–574
J Clin Invest 99:194–199 Peral B, SanMilla´n JL, Ong ACM,Gamble V,Ward CJ, Strong
Brook-Carter PT, Peral B, Ward CJ, Thompson P, Hughes J, C, Harris PC (1996) Screening the 3 region of the polycystic
Maheshwar M, Nellist M, et al (1994) Deletion of the TSC2 kidney disease 1 (PKD1) gene reveals six novel mutations.
and PKD1 genes associated with severe infantile polycystic Am J Hum Genet 58:86–96
kidney disease—a contiguous gene syndrome. Nat Genet 8: Qian F, Watnick TJ, Onuchic LF, Germino GG (1996) The
328–332 molecular basis of focal cyst formation in human autosomal
Campos A, Figueroa ET, Gunasekaran S, Garin E (1993) Early dominant polycystic kidney disease type 1. Cell 87:979–
presentation of tuberous sclerosis as bilateral renal cysts. J 987
Urol 149:1077–1079 Roach ES, Smith M, Huttenlocher P, Bhat M, Alcorn D, Haw-
Cockcroft DW, Gault MH (1976) Prediction of creatinine ley L (1992) Report of the Diagnostic Criteria Committee
clearance from serum creatinine. Nephron 16:31–41 of the National Tuberous Sclerosis Association. J Child Neu-
Cook JA, Oliver K, Mueller RF, Sampson JR (1996) A cross- rol 7:221–224
sectional study of renal involvement in tuberous sclerosis. J Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning:
Med Genet 33:480–484 a laboratory manual, 2d ed. Cold Spring Harbor Laboratory
Cree JE (1969) Tuberous sclerosis with polycystic kidneys. Press, Cold Spring Harbor, NY
Proc R Soc Med 62:327 Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976)
Elkin M, Bernstein J (1969) Cystic disease of the kidney: radio- A simple estimate of glomerular ﬁltration rate in children
logical and pathological considerations. Clin Radiol 20:65– derived from body length and plasma creatinine. Pediatrics
82 58:259–263
European Chromosome 16 Tuberous Sclerosis Consortium, Shepherd CW, Gomez MR, Lie JT (1991) Causes of death in
The (1993) Identiﬁcation and characterisation of the tuber- patients with tuberous sclerosis. Mayo Clin Proc 66:792–
ous sclerosis gene on chromosome 16. Cell 75:1305–1315 796
European Polycystic Kidney Disease Consortium, The (1994) Stapleton FB, Johnson D, Kaplan GW, Griswold W (1980)
The polycystic kidney disease 1 gene encodes a 14kb tran- The cystic renal lesion in tuberous sclerosis. J Pediatr 97:
script and lies within a duplicated region on chromosome 574–579
16. Cell 77:881–894 Torres VE, King BF, Holley KE, Blute ML, Gomez MR (1994)
Fryer AE, Chalmers A, Connor JM, Fraser I, Povey S, Yates The kidney in tuberous sclerosis. Adv Nephrol 23:43–70
A, Yates J, et al (1987) Evidence that the gene for tuberous Turco AE, Rosseti S, Bresin E, Corra S, Gammaro L, Maschio
sclerosis is on chromosome 9. Lancet 1:659–661 G, Pignatti PF (1995) A novel nonsense mutation in the
Gomez MR (1988) Tuberous sclerosis, 2d ed. Raven Press, PKD1 gene (C3817T) is associated with autosomal domi-
New York nant polycystic kidney disease (ADPKD) in a large three
Harris PC, Thomas S, Ratcliffe PJ, Breuning MH, Coto E, generation Italian family. Hum Mol Genet 4:1331–1335
Lopez-Larrea C (1991) Rapid genetic analysis of families Ward CJ, Turley H, Ong ACM, ComleyM, Biddolph S, Chetty
with polycystic kidney disease 1 by means of a microsatellite R, Ratcliffe P, et al (1996) Polycystin, the polycystic kidney
marker. Lancet 338:1484–1487 disease 1 protein, is expressed by epithelial cells in fetal,
Hermann BG, Barlow DP, Lehrach H (1987) A large inverted adult, and polycystic kidney. Proc Natl Acad Sci USA 93:
duplication allows homologous recombination between 1524–1528
chromosomes heterozygous for the proximal t complex in- Webb DW, Super M, Normand CS, Osborne JP (1993) Tuber-
version. Cell 48:813–825 ous sclerosis and polycystic kidney disease. BMJ 306:1258–
Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Milan 1259
J, Gamble V, et al (1995) The polycystic kidney disease Wenzl JE, Largos JC, Albers DD (1970) Tuberous sclerosis
1 (PKD1) gene encodes a novel protein with multiple cell presenting as polycystic kidneys in an infant. J Pediatr 77:
673–676recognition domains. Nat Genet 10:151–159
/ 9a38$$oc18 09-15-97 13:12:57 ajhgal UC-AJHG
